HS
Hitesh Shatrughan Nagpal
About Hitesh Shatrughan Nagpal
Data last updated:
Hitesh Shatrughan Nagpal is a Director at Curum Pharmaceutical Private Limited (since 2023). The company operates in Pharma. Curum Pharmaceutical Private Limited reported revenue of ₹4.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Curum Pharmaceutical Private Limited U47721MH2023PTC398641 | Director | 10 Mar 2023 | 2023 | ₹4.5 Lakh (FY 2025) | Active |
Board colleagues of Hitesh Shatrughan Nagpal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gajanan Choudhary | 10066034 | Curum Pharmaceutical Private Limited | Director |
| Jayashri Bhavesh Chopkar | 10066035 | Curum Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hitesh Shatrughan Nagpal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hitesh Shatrughan Nagpal
Hitesh Shatrughan Nagpal currently holds 1 directorship: Curum Pharmaceutical Private Limited (Director, since 10 Mar 2023, revenue ₹4.5 Lakh (FY 2025)).
Hitesh Shatrughan Nagpal was first appointed on 10 Mar 2023 as Director at Curum Pharmaceutical Private Limited.
The current boards of Hitesh Shatrughan Nagpal's companies include Gajanan Choudhary (Curum Pharmaceutical Private Limited), Jayashri Bhavesh Chopkar (Curum Pharmaceutical Private Limited).